~~<i id='84E9B9E5E6'><strike id='84E9B9E5E6'><tt id='84E9B9E5E6'><pre id='84E9B9E5E6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

focus

author：focus 2025-09-06 02:05:50 - browse：54586

the shape of a medical note connected by dots and lines — health tech coverage from STAT — Adobe

In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： First Opinion Podcast: What happens when kids become caregivers?

hotspot

leisure time

hotspot

leisure time

Wikipedia

hotspot

BRENDANSMIALOWSKI/AFPviaGettyImagesCommunityHealthSystemsisfacinganewfederalprobeintoitshospitalbill

WSS

iTeos Therapeutics debuts first data on TIGIT

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

What will save rural psychiatry services? Higher Medicaid payments

Alabama hospital puts IVF treatments on hold

A solution to the after

Obesity drugs seen as possible treatment for liver disease MASH

entertainment

focus

hotspot

Heart attack and stroke risk calculators need revising

A new nitrogen execution bill also undermines medical licensing

Dobbs anniversary: the lost opportunity of abortion as health care

Prosthetic arm enables patients to feel the objects they grip

Wildfire smoke exposes gaps in outdoor worker protections

Obesity drugs seen as possible treatment for liver disease MASH

Medicare details structure of new drug price negotiation program

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Walensky prepares to leave CDC — and Congress — behind

He's a Nobel laureate. Critics say he was misleading on Covid

leisure time

Community Health Systems hospitals under DOJ investigation

Report: NIH

Do more moles mean more problems? Not so, says new study

AI used to predict Covid

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Ed Silverman on new gene therapies, biosimilars, coffee, and more

hotspot

leisure time

Wikipedia

hotspot